The global neoantigen cancer vaccine market was valued at USD 24.4 million in 2022, and it will advance at a mammoth 67.6% compound annual growth rate, to touch USD 1,322.8 million, by 2030.To learn more about this report: https://bit.ly/47EUjP7The key factor boosting the advancement...
